Sign Up Today and Learn More About Cockroach Labs Stock
Invest in or calculate the value of your shares in Cockroach Labs or other pre-IPO companies through EquityZen's platform.
Cockroach Labs Stock (COLA)
open-Source Distributed SQL Database
Cockroach Labs develops CockroachDB, an open-source, distributed SQL database that aims to be consistent, scalable, and survivable.
About Cockroach Labs Stock
Founded
2015
Headquarters
New York, NY, US
Total Funding
634M
Industries
Software, Artificial Intelligence, Data and Analytics
Cockroach Labs develops CockroachDB, an open-source, distributed SQL database that aims to be consistent, scalable, and survivable. It aims to provide enterprise-grade disaster recovery.
The company was founded in 2015 and is headquartered in New York City. Notable investors including Benchmark, G/V, Index Ventures, Redpoint, and Sequoia.
Cockroach Labs Press Mentions
Stay in the know about the latest news on Cockroach Labs
Cockroach Labs Sets a New Benchmark in Enterprise Resilience with Next-Generation AI Capabilities and Enhanced Cloud Tiers
prnewswire • Sep 26, 2024
CockroachDB scurries off to proprietary software land
theregister • Aug 24, 2024
CockroachDB scuttles away from open source Core offering
theregister • Aug 20, 2024
Cockroach Labs partners with PwC UK
thepaypers • Aug 13, 2024
Cockroach Labs and PwC UK Announce Strategic Collaboration, Delivering Solutions for Operational Resiliency, Data Sovereignty, and Mainframe Modernization
prnewswire • Aug 12, 2024
Investors in Cockroach Labs
Discover investors in Cockroach Labs stock and explore their portfolio companies
Cockroach Labs Management
Leadership team at Cockroach Labs
Chief Executive Officer
Spencer Kimball
Chief Financial Officer
Lorenzo Montesi
Join now and verify your accreditation status to gain access to:
- Cockroach Labs current valuation
- Cockroach Labs stock price
- Available deals in Cockroach Labs and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Cockroach Labs stock?
Accredited investors can buy pre-IPO stock in companies like Cockroach Labs through EquityZen funds. These investments are made available by existing Cockroach Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cockroach Labs stock?
Shareholders can sell their Cockroach Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
